Genitourinary Tumors With Sacituzumab Tirumotecan

Clinical trial NCT07716917 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07716917
Sponsor: Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Papillary Renal Carcinoma Variant Histology Urothelial Carcinoma

Start date: 2026-10-01
Primary completion: 2029-10-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.